We hereby submit Outcome of the board meeting held on September 03, 2026

Exporter & Trader of Speciality Medicines Date: 03/09/2026 BSE Limited. PJ Towers, Dalal Street, Mumbai – 400001 Sub: Outcome of Board meeting held on September 03, 2026 Reference: Speciality Medicines Limited (Id: SPML; Code: 544738) In reference to captioned subject, we hereby inform you that the Board of Directors of the Company has, in their Board Meeting held on today, i.e. on Thursday, September 03, 2026, at the Corporate Office of the Company which was commenced at 03:00 P.M. and concluded at 03:40 P.M., have, apart from other businesses, considered and approved; 1. Draft Directors’ Report for the financial year 2025-26 along with its Annexures and other reports to be included in the Annual Report 2025-26. 2. Decided to call the 5th Annual General Meeting of the Company on Monday, September 28, 2026 at 11.00 A.M. IST through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) in compliance with the applicable circulars of Ministry of Corporate Affairs (MCA) and SEBI and approved the Draft Notice of 5th Annual General Meeting of the Company. Since entire shareholding is in the dematerialised form, the Register of Members and Share Transfer Books of the Company will not be closed. Members whose names are recorded in the Register of Members or in the Register of Beneficial Owners maintained by the Depositories as on the Cut-off date i.e. Monday, September 21, 2026, shall be entitled to avail the facility of remote e-voting as well as e- voting system on the date of the AGM. The copy of Notice of 5th Annual General Meeting and Annual Report for the financial year 2025-26 will be submitted to exchange as soon as the same be dispatched to the Shareholders of the Company through Email. 3. Appointed National Securities Depository Limited (NSDL) as Remote E-Voting Agency for resolutions proposed to be passed at Annual General Meeting. 4. Appointed CS Hardikkumar Jetani, Practicing Company Secretary (Membership No. FCS: 13678; CP No: 22171) as Scrutinizer, who has consented as such, for conducting the remote e-voting process as well as the e-voting system on the date of the Annual General Meeting, in a fair and transparent manner. Kindly take the same on your record and oblige us. Thanking you, Yours Faithfully, For, SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) SUMIT GOYANI Whole-Time Director DIN: 07885780 Place: Mumbai SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) CIN: L85300GJ2021PLC120022 Corp. Office : Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, 20 Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra, India, 400093 Regd. Office : 913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmedabad 380051, Gujarat, India +91 99242 03751 / 99242 43751 info@specialitymedicine.com www.specialitymedicine.com